Evidence map›Paper›PMID 33591980›Full record

ArticlePLoS neglected tropical diseases2021

Accelerating elimination of sleeping sickness from the Guinean littoral through enhanced screening in the post-Ebola context: A retrospective analysis.

Oumou Camara, Sylvain Biéler, Bruno Bucheton, Moïse Kagbadouno, Joseph Mathu Ndung'u, Philippe Solano, Mamadou Camara

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. [Towards elimination of human African trypanosomiasis].Medecine tropicale et sante internationale · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Oumou CamaraProgramme National de Lutte contre la Trypanosomiase Humaine Africaine, Conakry, Guinea.
Sylvain BiélerFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.ORCID 0000-0001-6994-9853
Bruno BuchetonInstitut de Recherche pour le Développement (IRD), INTERTRYP, CIRAD, Université de Montpellier, Montpellier, France.ORCID 0000-0003-3804-5426
Moïse KagbadounoProgramme National de Lutte contre la Trypanosomiase Humaine Africaine, Conakry, Guinea.
Joseph Mathu Ndung'uFoundation for Innovative New Diagnostics (FIND), Geneva, Switzerland.
Philippe SolanoInstitut de Recherche pour le Développement (IRD), INTERTRYP, CIRAD, Université de Montpellier, Montpellier, France.ORCID 0000-0002-4351-3506
Mamadou CamaraProgramme National de Lutte contre la Trypanosomiase Humaine Africaine, Conakry, Guinea.
Centre de Coopération Internationale en Recherche Agronomique pour le Développement · FRFIND · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundActivities to control human African trypanosomiasis (HAT) in Guinea were severely hampered by the Ebola epidemic that hit this country between 2014 and 2016. Active screening was completely interrupted and passive screening could only be maintained in a few health facilities. At the end of the epidemic, medical interventions were progressively intensified to mitigate the risk of HAT resurgence and progress towards disease elimination. METHODOLOGY/PRINCIPAL

findingsA retrospective analysis was performed to evaluate the medical activities that were implemented in the three most endemic prefectures of Guinea (Boffa, Dubreka and Forecariah) between January 2016 and December 2018. Passive screening using rapid diagnostic tests (RDTs) was progressively resumed in one hundred and one health facilities, and active screening was intensified by visiting individual households and performing RDTs, and by conducting mass screening in villages by mobile teams using the Card Agglutination Test for Trypanosomiasis. A total of 1885, 4897 and 8023 clinical suspects were tested in passive, while 5743, 14442 and 21093 people were actively screened in 2016, 2017 and 2018, respectively. The number of HAT cases that were diagnosed first went up from 107 in 2016 to 140 in 2017, then subsequently decreased to only 73 in 2018. A progressive decrease in disease prevalence was observed in the populations that were tested in active and in passive between 2016 and 2018. CONCLUSIONS/SIGNIFICANCE: Intensified medical interventions in the post-Ebola context first resulted in an increase in the number of HAT cases, confirming the fear that the disease could resurge as a result of impaired control activities during the Ebola epidemic. On the other hand, the decrease in disease prevalence that was observed between 2016 and 2018 is encouraging, as it suggests that the current strategy combining enhanced diagnosis, treatment and vector control is appropriate to progress towards elimination of HAT in Guinea.

Indexed as

Diagnostic Tests, RoutineGuineaHemorrhagic Fever, EbolaHumansMass ScreeningPrevalenceRetrospective StudiesTrypanosoma brucei gambienseTrypanosomiasis, African

Identifiers

PMID33591980
PMCPMC7909630
OpenAlexW3129344625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.